Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Recruiting 5Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 4Other 2Breast 1

Conditions

Obesity 2Hyperplasia 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Breast Neoplasms 1

Interventions

Tirzepatide 2Exercise 2Bariatric Surgery 2semaglutide 1mirogabalin 1exemestane 1Standard of Care 1Sex Education 1Resistance Training 1Progestins 1Patient Navigation 1Oxycodone 1Nutrition Assessment 1Mindfulness 1Metformin 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Low-Level Light Therapy 1Leuprolide 1Letrozole 1Hysteroscopy 1Hepatectomy 1Goserelin 1Gonadotropin-Releasing Hormone 1Fecal Microbiota Transplantation 1Estrogen Replacement Therapy 1Duloxetine Hydrochloride 1Diet Therapy 1Diet 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Tirzepatide × Other × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Weill Medical College of Cornell University

Phase 4 Not yet recruiting
30 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡